Literature DB >> 2787714

A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.

E Filley1, A Andreoli, J Steele, M Waters, D Wagner, D Nelson, K Tung, T Rademacher, R Dwek, G A Rook.   

Abstract

The proportion of oligosaccharide chains on the Fc fragment of IgG which terminate with N-acetylglucosamine and not galactose (%GO) has previously been shown to be raised in rheumatoid arthritis (RA), Crohn's disease (CD) and tuberculosis (Tb), but to be normal in sarcoidosis (SA), and in both lepromatous and tuberculoid leprosy. However we have now studied %GO in sequential serum samples collected from lepromatous leprosy patients undergoing episodes of erythema nodosum leprosum (ENL). During ENL %GO is transiently raised, and this rise parallels an increase in circulating interleukin 2 receptors (IL-2R). These findings confirm that changes in T cell function occur during ENL. Moreover it appears that %GO rises when there is, simultaneously, T-cell-mediated tissue damage and an acute phase response (RA, CD, Tb, ENL), but not when there is an acute phase response without major T cell involvement, or chronic T cell activity alone (SA, and tuberculoid leprosy). We suggest therefore that %GO is an indicator of a type of T cell activity with broad immunopathological implications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787714      PMCID: PMC1541882     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Rheumatoid arthritis, mycobacterial antigens and agalactosyl IgG.

Authors:  G A Rook
Journal:  Scand J Immunol       Date:  1988-10       Impact factor: 3.487

Review 2.  The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.

Authors:  T W Rademacher; R B Parekh; R A Dwek; D Isenberg; G Rook; J S Axford; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis.

Authors:  W van Eden; J E Thole; R van der Zee; A Noordzij; J D van Embden; E J Hensen; I R Cohen
Journal:  Nature       Date:  1988-01-14       Impact factor: 49.962

4.  A monoclonal antibody raised by immunising mice with group A streptococci binds to agalactosyl IgG from rheumatoid arthritis.

Authors:  G A Rook; J Steele; T Rademacher
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

5.  Clinical and laboratory studies of inflammatory polyarthritis in patients with leprosy in Papua New Guinea.

Authors:  S L Atkin; R R Welbury; E Stanfield; D Beavis; B Iwais; W C Dick
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

6.  Soluble serum interleukin 2 receptor levels in leprosy patients.

Authors:  K S Tung; E Umland; P Matzner; K Nelson; V Schauf; L Rubin; D Wagner; D Scollard; P Vithayasai; V Vithayasai
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  The spontaneous ability of normal human IgG to inhibit the Fc receptors of normal human monocytes is related to their binding capacity to lectins.

Authors:  M G Malaise; P Franchimont; F Gomez; C Bouillenne; P R Mahieu
Journal:  Clin Immunol Immunopathol       Date:  1987-10

8.  In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.

Authors:  R L Modlin; V Mehra; R Jordan; B R Bloom; T H Rea
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

9.  Reduced B-cell galactosyltransferase activity in rheumatoid arthritis.

Authors:  J S Axford; L Mackenzie; P M Lydyard; F C Hay; D A Isenberg; I M Roitt
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  15 in total

1.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 2.  The importance of oligosaccharides to rheumatic disease: a personal perspective.

Authors:  J S Axford
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

Review 3.  A reappraisal of the evidence that rheumatoid arthritis and several other idiopathic diseases are slow bacterial infections.

Authors:  G A Rook; P M Lydyard; J L Stanford
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

4.  A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy.

Authors:  G A Rook; P Onyebujoh; E Wilkins; H M Ly; R al Attiyah; G Bahr; T Corrah; H Hernandez; J L Stanford
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

5.  Agalactosyl IgG, antibodies to heat shock proteins, and acute rheumatic fever.

Authors:  G M Bahr; A M Yousof; H A Majeed; K Behbehani; M Lubani; R B Parekh; R A Dwek; T W Rademacher; D B Young; A Mehlert
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

6.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients.

Authors:  A Youings; S C Chang; R A Dwek; I G Scragg
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

7.  Glycosylation of IgG during potentially arthritogenic lentiviral infections.

Authors:  J McCulloch; Y W Zhang; M Dawson; G D Harkiss; E Peterhans; H R Vogt; P M Lydyard; G A Rook
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

8.  Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.

Authors:  R Dubé; G A Rook; J Steele; R Brealey; R Dwek; T Rademacher; J Lennard-Jones
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

9.  Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.

Authors:  J S Axford; N Sumar; A Alavi; D A Isenberg; A Young; K B Bodman; I M Roitt
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  IgG glycosylation in autoimmune-prone strains of mice.

Authors:  K B Bodman; P R Hutchings; P A Jeddi; P J Delves; G A Rook; N Sumar; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.